RECOVER-TLC: The Next Phase in Long COVID Clinical Trials
NIAID is leading the next stage of clinical trials to help Long COVID patients.
Volunteer for Mpox Clinical Study
STOMP is an NIAID-funded clinical trial to evaluate the efficacy of the antiviral tecovirimat, also know as TPOXX, for the treatment of mpox. If you think you might have mpox, find out more and volunteer.
Dr. Marrazzo began her tenure as the sixth NIAID Director in the fall of 2023. She oversees a $6.6 billion budget that supports research to advance the understanding, diagnosis, treatment and prevention of infectious, immunologic, and allergic diseases. She is internationally recognized for her research and education efforts in the field of sexually transmitted infections, especially as they affect women’s health.
